Immunoscintigraphy of small-cell lung cancer xenografts with anti neural cell adhesion molecule monoclonal antibody, 123C3: improvement of tumour uptake by internalisation
1996

Immunoscintigraphy of Small-Cell Lung Cancer with Monoclonal Antibody 123C3

Sample size: 5 publication Evidence: moderate

Author Information

Author(s): HB Kwal, J Wesseling, AHM Verhoeven, N van Zandwijk, J Hilkens

Primary Institution: The Netherlands Cancer Institute

Hypothesis

The study investigates whether internalisation of monoclonal antibodies can improve tumour uptake in small-cell lung cancer.

Conclusion

The internalisation of radiolabelled monoclonal antibody 123C3 leads to higher accumulation and retention of radioactivity in tumour tissue compared to other antibodies.

Supporting Evidence

  • MAb 123C3 showed a higher tumour uptake than MAbs 123A8 and MOCl91.
  • Internalisation of MAb 123C3 was confirmed by various imaging techniques.
  • The tumour to blood ratio for MAb 123C3 was significantly higher than for the other MAbs.

Takeaway

Researchers found that a special antibody can get inside cancer cells better than others, helping doctors see the cancer more clearly in scans.

Methodology

The study used a Balb/c nu/nu mouse model to evaluate the efficacy of three monoclonal antibodies for immunoscintigraphy of small-cell lung cancer xenografts.

Limitations

The study does not address potential side effects of the antibodies in human tissues.

Participant Demographics

Balb/c nu/nu mice were used in the study.

Statistical Information

P-Value

0.04

Statistical Significance

p=0.04

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication